Centers for Medicare & Medicaid Services (CMS) issued a July 24 notice announcing they are currently granting conditional approval for CY24 formularies. Formularies in an approved status will be eligible for updating during the summer window beginning August 3 and ending at 5 p.m. ET on August 7. Changes during this window are limited to those outlined in the memo.